Author:
Panteleeva G. P.,Oleichik I. V.,Abramova L. I.,Yumatova P. E.
Publisher
Media Sphere Publishing Group
Subject
Psychiatry and Mental health,Clinical Neurology
Reference23 articles.
1. Stahl S.M. Chto bolit pri depressii? (referat). Obozr psikhiatr i medpsikhol 2000; 4: 51—52.
2. Thase M.E., Entsuah A.R., Rudolph R.L. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry 2001; 178: 234—241.
3. Vermeiden M.L., Mulder P.G., van den Broek W.W., Bruijn J.A. A double-blind randomized study comparing plasma level-targeted dose imipramine and high-dose venlafaxine in depressed inpatients. J Psychiatr Res 2013; 47: 10: 1337—1342.
4. Mosolov S.N., Kostyukova E.G., Gorodnichev A.V., Timofeev I.V., Ladyzhenskii M.Ya., Serditov O.V. Klinicheskaya effektivnost' i perenosimost' preparata venlafaksin (velaksin) pri lechenii umerennoi i tyazheloi depressii. Trudnyi patsient 2007; 11: 72—78.
5. Llorca P.M., Fernandez J.L. Escitalopram in the treatment of major depressive disorder: clinical efficacy, tolerability and cost-effectiveness vs. venlafaxine extended-release formulation. Int J ClinPract 2007; 61: 4: 702—710.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献